Skip to content
Recall Observatory FDA recall evidence

Drug product

Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01

D-1252-2020

April 15, 2020

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 85487
Status
Terminated
Classification
Class II
Quantity
4,518 bottles
Official record key
drug-enforcement:D-1252-2020

Official wording

Reason: Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.

Code information: Lot #: F800779, Expiry 4/2020

Distribution pattern: Nationwide with the United States and Puerto Rico.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent

Field note

Send feedback

We'll only use this to respond to your feedback.